Literature DB >> 19870673

PROPERTIES OF THE TYPE SPECIFIC PROTEINS OF ANTIPNEUMOCOCCUS SERA : I. THE MOUSE PROTECTIVE VALUE OF TYPE I SERA WITH REFERENCE TO THE PRECIPITIN CONTENT.

K Goodner1, F L Horsfall.   

Abstract

The ability to carry out with some measure of precision mouse protection tests for the estimation of potency of antipneumococcus sera has made possible the correlation of the protective potency with the amount of specifically precipitable protein. With antipneumococcus rabbit sera these protective ratios are relatively constant and higher than those with immune horse serum. Type I antipneumococcus horse sera, on the other hand, show no such constancy but fall into two groups; and there is as yet no simple method for determining to which group a serum belongs.

Entities:  

Year:  1937        PMID： 19870673      PMCID： PMC2133582          DOI： 10.1084/jem.66.4.413

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  9 in total

1.  THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN MICE : I. THE QUANTITATIVE ASPECTS OF THE MOUSE PROTECTION TEST.

Authors:  K Goodner; F L Horsfall
Journal:  J Exp Med       Date:  1935-08-31       Impact factor: 14.307

2.  THE MOLECULAR WEIGHT OF ANTIBODIES.

Authors:  M Heidelberger; K O Pedersen
Journal:  J Exp Med       Date:  1937-02-28       Impact factor: 14.307

3.  LIPIDS AND IMMUNOLOGICAL REACTIONS : III. LIPID CONTENT OF SPECIFIC PRECIPITATES FROM TYPE I ANTIPNEUMOCOCCUS SERA.

Authors:  F L Horsfall; K Goodner
Journal:  J Exp Med       Date:  1936-09-30       Impact factor: 14.307

4.  SPECIFIC PRECIPITATION AND MOUSE PROTECTION IN TYPE I ANTIPNEUMOCOCCUS SERA.

Authors:  M Heidelberger; R H Sia; F E Kendall
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

5.  QUANTITATIVE STUDIES ON ANTIBODY PURIFICATION : I. THE DISSOCIATION OF PRECIPITATES FORMED BY PNEUMOCOCCUS SPECIFIC POLYSACCHARIDES AND HOMOLOGOUS ANTIBODIES.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1936-07-31       Impact factor: 14.307

6.  THE SPECIFIC POLYSACCHARIDES OF TYPES I, II, AND III PNEUMOCOCCUS : A REVISION OF METHODS AND DATA.

Authors:  M Heidelberger; F E Kendall; H W Scherp
Journal:  J Exp Med       Date:  1936-09-30       Impact factor: 14.307

7.  THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN MICE : V. THE EFFECT OF ADDED LIPIDS ON THE PROTECTIVE MECHANISM.

Authors:  K Goodner; F L Horsfall
Journal:  J Exp Med       Date:  1936-08-31       Impact factor: 14.307

8.  IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : IV. STATISTICAL STUDIES OF ELEMENTARY BODIES IN RELATION TO INFECTION AND AGGLUTINATION.

Authors:  R F Parker; T M Rivers
Journal:  J Exp Med       Date:  1936-08-31       Impact factor: 14.307

9.  THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND HOMOLOGOUS ANTIBODY : II. CONDITIONS FOR QUANTITATIVE PRECIPITATION OF ANTIBODY IN HORSE SERA.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1935-03-31       Impact factor: 14.307
  9 in total
  7 in total

1.  Crystalline pneumococcus antibody.

Authors:  J H NORTHROP; W F GOEBEL
Journal:  J Gen Physiol       Date:  1949-07       Impact factor: 4.086

2.  PROPERTIES OF THE TYPE SPECIFIC PROTEINS OF ANTIPNEUMOCOCCUS SERA : II. IMMUNOLOGICAL FRACTIONATION OF TYPE I ANTIPNEUMOCOCCUS HORSE AND RABBIT SERA.

Authors:  K Goodner; F L Horsfall
Journal:  J Exp Med       Date:  1937-09-30       Impact factor: 14.307

3.  QUANTITATIVE STUDIES ON ANTIBODY PURIFICATION : II. THE DISSOCIATION OF ANTIBODY FROM PNEUMOCOCCUS SPECIFIC PRECIPITATES AND SPECIFICALLY AGGLUTINATED PNEUMOCOCCI.

Authors:  M Heidelberger; E A Kabat
Journal:  J Exp Med       Date:  1938-01-31       Impact factor: 14.307

4.  STUDIES ON MENINGOCOCCAL INFECTION : XIII. CORRELATION BETWEEN ANTIPOLYSACCHARIDE AND THE ANTIBODY WHICH PROTECTS MICE AGAINST INFECTION WITH TYPE I MENINGOCOCCI.

Authors:  H W Scherp; G Rake
Journal:  J Exp Med       Date:  1945-01-01       Impact factor: 14.307

5.  PROPERTIES OF THE TYPE SPECIFIC PROTEINS OF ANTIPNEUMOCOCCUS SERA : III. IMMUNOCHEMICAL FRACTIONATION OF TYPE I ANTIPNEUMOCOCCUS HORSE AND RABBIT SERA.

Authors:  K Goodner; F L Horsfall
Journal:  J Exp Med       Date:  1937-09-30       Impact factor: 14.307

6.  MOUSE-PROTECTIVE TITERS OF SERA OF VOLUNTEERS FOLLOWING INJECTION OF PNEUMOCOCCI OR THEIR TYPE-SPECIFIC POLYSACCHARIDES.

Authors:  A W Walter; E L Schenkein; W D Sutliff
Journal:  J Exp Med       Date:  1946-03-31       Impact factor: 14.307

7.  Agglutinating efficiency and combining capacity of Shigella and Vibrio antisera from rabbits at different stages of immunization.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1957-06-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.